ATE198148T1 - Formulierungen von verbindungen als nanopartikel dispergiert in verdaubaren ölen oder fettsäuren - Google Patents
Formulierungen von verbindungen als nanopartikel dispergiert in verdaubaren ölen oder fettsäurenInfo
- Publication number
- ATE198148T1 ATE198148T1 AT96904552T AT96904552T ATE198148T1 AT E198148 T1 ATE198148 T1 AT E198148T1 AT 96904552 T AT96904552 T AT 96904552T AT 96904552 T AT96904552 T AT 96904552T AT E198148 T1 ATE198148 T1 AT E198148T1
- Authority
- AT
- Austria
- Prior art keywords
- formulations
- compounds
- fatty acids
- nanoparticles dispersed
- digestible oils
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 235000014113 dietary fatty acids Nutrition 0.000 title 1
- 229930195729 fatty acid Natural products 0.000 title 1
- 239000000194 fatty acid Substances 0.000 title 1
- 150000004665 fatty acids Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000002105 nanoparticle Substances 0.000 title 1
- 239000003921 oil Substances 0.000 title 1
- 239000008346 aqueous phase Substances 0.000 abstract 1
- 229940088679 drug related substance Drugs 0.000 abstract 1
- 230000001926 lymphatic effect Effects 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nanotechnology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medical Informatics (AREA)
- Dispersion Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Fats And Perfumes (AREA)
- Edible Oils And Fats (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/384,057 US5571536A (en) | 1995-02-06 | 1995-02-06 | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
| US08/388,088 US5560931A (en) | 1995-02-14 | 1995-02-14 | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
| PCT/US1996/001433 WO1996024332A1 (en) | 1995-02-06 | 1996-01-31 | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE198148T1 true ATE198148T1 (de) | 2001-01-15 |
Family
ID=27010448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96904552T ATE198148T1 (de) | 1995-02-06 | 1996-01-31 | Formulierungen von verbindungen als nanopartikel dispergiert in verdaubaren ölen oder fettsäuren |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0808154B1 (de) |
| JP (1) | JPH10513200A (de) |
| AT (1) | ATE198148T1 (de) |
| AU (1) | AU4862796A (de) |
| CA (1) | CA2207304A1 (de) |
| DE (1) | DE69611287T2 (de) |
| DK (1) | DK0808154T3 (de) |
| ES (1) | ES2154806T3 (de) |
| GR (1) | GR3035613T3 (de) |
| PT (1) | PT808154E (de) |
| WO (1) | WO1996024332A1 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2736550B1 (fr) | 1995-07-14 | 1998-07-24 | Sandoz Sa | Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule |
| US7255877B2 (en) | 1996-08-22 | 2007-08-14 | Jagotec Ag | Fenofibrate microparticles |
| US6045829A (en) * | 1997-02-13 | 2000-04-04 | Elan Pharma International Limited | Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers |
| AU761205B2 (en) * | 1998-03-30 | 2003-05-29 | Skyepharma Canada Inc. | Composition and method of preparing microparticles of water-insoluble substances |
| US6337092B1 (en) | 1998-03-30 | 2002-01-08 | Rtp Pharma Inc. | Composition and method of preparing microparticles of water-insoluble substances |
| US6979456B1 (en) | 1998-04-01 | 2005-12-27 | Jagotec Ag | Anticancer compositions |
| US20050048126A1 (en) | 2000-12-22 | 2005-03-03 | Barrett Rabinow | Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug |
| US6884436B2 (en) | 2000-12-22 | 2005-04-26 | Baxter International Inc. | Method for preparing submicron particle suspensions |
| US7193084B2 (en) | 2000-12-22 | 2007-03-20 | Baxter International Inc. | Polymorphic form of itraconazole |
| US6977085B2 (en) | 2000-12-22 | 2005-12-20 | Baxter International Inc. | Method for preparing submicron suspensions with polymorph control |
| US9700866B2 (en) | 2000-12-22 | 2017-07-11 | Baxter International Inc. | Surfactant systems for delivery of organic compounds |
| US6951656B2 (en) | 2000-12-22 | 2005-10-04 | Baxter International Inc. | Microprecipitation method for preparing submicron suspensions |
| US8067032B2 (en) | 2000-12-22 | 2011-11-29 | Baxter International Inc. | Method for preparing submicron particles of antineoplastic agents |
| US6607784B2 (en) | 2000-12-22 | 2003-08-19 | Baxter International Inc. | Microprecipitation method for preparing submicron suspensions |
| US20060003012A9 (en) | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
| MXPA04002446A (es) | 2001-09-26 | 2004-07-23 | Baxter Int | Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente. |
| US7112340B2 (en) | 2001-10-19 | 2006-09-26 | Baxter International Inc. | Compositions of and method for preparing stable particles in a frozen aqueous matrix |
| US8426467B2 (en) | 2007-05-22 | 2013-04-23 | Baxter International Inc. | Colored esmolol concentrate |
| US8722736B2 (en) | 2007-05-22 | 2014-05-13 | Baxter International Inc. | Multi-dose concentrate esmolol with benzyl alcohol |
| US20110263422A1 (en) * | 2008-12-18 | 2011-10-27 | Basf Se | Aqueous dispersion comprising pesticide particles and an amphiphile |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2714065A1 (de) * | 1977-03-30 | 1978-10-12 | Boehringer Mannheim Gmbh | Instillationszubereitung |
| DE3623376A1 (de) * | 1986-07-11 | 1988-01-21 | Behringwerke Ag | Pharmazeutische formulierung und verfahren zu deren herstellung |
| IL88076A (en) * | 1987-10-28 | 1993-01-14 | Nippon Shinyaku Co Ltd | Fat emulsions as drug carriers |
| GB8822857D0 (en) * | 1988-09-29 | 1988-11-02 | Patralan Ltd | Pharmaceutical formulations |
| GB9022788D0 (en) * | 1990-10-19 | 1990-12-05 | Cortecs Ltd | Pharmaceutical formulations |
| US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| GB9300875D0 (en) * | 1993-01-18 | 1993-03-10 | Ucb Sa | Nanocapsule containing pharmaceutical compositions |
-
1996
- 1996-01-31 WO PCT/US1996/001433 patent/WO1996024332A1/en not_active Ceased
- 1996-01-31 ES ES96904552T patent/ES2154806T3/es not_active Expired - Lifetime
- 1996-01-31 DK DK96904552T patent/DK0808154T3/da active
- 1996-01-31 EP EP96904552A patent/EP0808154B1/de not_active Expired - Lifetime
- 1996-01-31 PT PT96904552T patent/PT808154E/pt unknown
- 1996-01-31 JP JP8524341A patent/JPH10513200A/ja not_active Ceased
- 1996-01-31 AU AU48627/96A patent/AU4862796A/en not_active Abandoned
- 1996-01-31 AT AT96904552T patent/ATE198148T1/de not_active IP Right Cessation
- 1996-01-31 CA CA002207304A patent/CA2207304A1/en not_active Abandoned
- 1996-01-31 DE DE69611287T patent/DE69611287T2/de not_active Expired - Fee Related
-
2001
- 2001-03-20 GR GR20010400459T patent/GR3035613T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK0808154T3 (da) | 2001-04-30 |
| PT808154E (pt) | 2001-06-29 |
| CA2207304A1 (en) | 1996-08-15 |
| AU4862796A (en) | 1996-08-27 |
| WO1996024332A1 (en) | 1996-08-15 |
| DE69611287D1 (de) | 2001-01-25 |
| GR3035613T3 (en) | 2001-06-29 |
| DE69611287T2 (de) | 2001-08-09 |
| EP0808154B1 (de) | 2000-12-20 |
| EP0808154A1 (de) | 1997-11-26 |
| JPH10513200A (ja) | 1998-12-15 |
| ES2154806T3 (es) | 2001-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69611287D1 (de) | Formulierungen von verbindungen als nanopartikel dispergiert in verdaubaren ölen oder fettsäuren | |
| US6110477A (en) | Stabilization of ascorbic acid, ascorbic acid derivatives and/or extracts containing ascorbic acid for topical use | |
| US5843411A (en) | Stabilization of ascorbic acid, ascorbic acid derivatives and/or extracts containing ascorbic acid for topical use | |
| ATE236627T1 (de) | Pharmazeutische zubereitung enhaltend eicosapentaensäure und/oder stearidonsäure | |
| FR2634376B1 (fr) | Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation | |
| DK1429731T3 (da) | Nanopartikelformuleringer indeholdende insulin | |
| IE910050A1 (en) | EFA compositions and therapy | |
| ATE55243T1 (de) | Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung. | |
| NO964433D0 (no) | Farmasöytiske preparater på basis av derivater av taxanklassen | |
| DE69629989D1 (de) | Präparate zur äusserlichen anwendung zur behandlung von dermatosen | |
| ATE172111T1 (de) | Arzneizusammensetzungen enthaltend nanokapseln | |
| ATE50499T1 (de) | Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe. | |
| ATE292455T1 (de) | Fettlösliche vitamine enthaltende zusammensetzungen | |
| IT1263840B (it) | Formulazioni orali di ubidecarenone in forma di capsule | |
| ID15895A (id) | Formulasi untuk menurunkan kolesterol darah dan penyerapan lemak berbagai fungsi | |
| ATE101036T1 (de) | Aktivitaetspotenziator gegen krebs. | |
| SE9801647D0 (sv) | Therapeutic composition | |
| GR3002216T3 (en) | Cosmetic product, particularly a skin hydratation product | |
| KR890015739A (ko) | 인터루킨-1 생합성 억제제인 3-치환된-2-옥신돌-1-카복사미드 | |
| DK0647129T3 (da) | Præparat til topisk anvendelse | |
| ATE110274T1 (de) | Mittel zur verbesserung spezifischer eigenschaften des blutes. | |
| ES2180065T3 (es) | Formulaciones de uso topico que contienen acetato de vitamina e. | |
| JP2004196665A5 (de) | ||
| KR940003570A (ko) | 개량된 방향제 조성물 | |
| KR960033456A (ko) | 항스트레스 의약조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |